The ASX dusted itself off after a brutal $63bn wipeout, with global markets rebounding and commodities and even crypto ...

The ASX clawed back as tech stocks bounced, but oil jitters from the Iran crisis, and China’s weaker growth outlook kept ...

A global maternal care and infant feeding company based in Greater Washington has a new CEO. She's plotting some changes for ...

Novartis agreed to acquire clinical-stage biopharmaceutical maker Tourmaline Bio Inc. in an all-cash deal worth around $1.4 billion.

A homegrown biopharma developing cell therapies for cancers and other diseases is set to be acquired by Gilead Sciences — for ...

Graphics Cards You might be as surprised as I was to learn that Assassin's Creed Mirage is one of the few games to use AI neural texture compression—the only one, I think AI Todd Howard says AI's 'not ...

The limited supply of this common reagent is set to drive drug prices higher, but there are ways for companies to lessen the impact. Biopharma is running into a structural squeeze: policymakers want ...

Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates.

TL;DR: Unity's upgraded AI, launching in beta at GDC, enables developers to create full casual games using natural language prompts without coding. Leveraging advanced models from OpenAI and Meta, ...

Just as a disciplined a soccer player might pass on a hopeful shot in favor of a better chance later on, the biopharma venture capital market reflected a preference for de-risked assts over platforms ...

Unity stock has tumbled twice recently, first after Google's Project Genie Reveal, and then after a disappointing earnings report. Project Genie is impressive, but it won't replace video game engines.